Endothelial transmigration by Trypanosoma cruzi

scientific article

Endothelial transmigration by Trypanosoma cruzi is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...881187C
P356DOI10.1371/JOURNAL.PONE.0081187
P8608Fatcat IDrelease_m7czepqkd5fjpbwomkqtnwgweq
P932PMC publication ID3846899
P698PubMed publication ID24312535
P5875ResearchGate publication ID259208979

P50authorDavid P SullivanQ59687590
P2093author name stringWilliam A Muller
Cheryl L Olson
David M Engman
Conrad L Epting
Bria M Coates
Ming Y Makanji
Nga Y Du
P2860cites workTrypanosoma cruzi: Entry into Mammalian Host Cells and Parasitophorous Vacuole FormationQ21131212
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas diseaseQ28391025
Blockade of endothelin ETA/ETB receptors favors a role for endothelin during acute Trypanosoma cruzi infection in ratsQ57612201
The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesisQ58439075
Trypanosoma cruzi: skin-penetration kinetics of vector-derived metacyclic trypomastigotesQ58846638
Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesisQ59063865
Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasitesQ71280047
CD99 plays a major role in the migration of monocytes through endothelial junctionsQ77550438
Breaking the wall: targeting of the endothelium by pathogenic bacteriaQ37664468
Chagas cardiomyopathy--where do we stand after a hundred years?Q37683028
Regulation of endothelial permeability via paracellular and transcellular transport pathwaysQ37690727
Molecular mechanisms of host cell invasion by Trypanosoma cruziQ37769831
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathyQ37781700
How does Staphylococcus aureus escape the bloodstream?Q37827983
Mechanisms of host cell invasion by Trypanosoma cruziQ37925205
Infection-associated vasculopathy in experimental chagas disease pathogenic roles of endothelin and kinin pathwaysQ37925208
Inflammation and Chagas disease some mechanisms and relevanceQ37925213
Relevance of endothelial junctions in leukocyte extravasation and vascular permeabilityQ38016501
Diagnosis and management of Chagas disease and cardiomyopathyQ38030830
Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stressQ39193707
Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policyQ39945115
Pathogenesis of Chagas disease: time to move on.Q40291208
Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99.Q41663783
Bioluminescent imaging of Trypanosoma cruzi infectionQ41760091
Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytesQ42152162
Modulation of autoimmunity by treatment of an infectious diseaseQ42432412
Parasite persistence correlates with disease severity and localization in chronic Chagas' diseaseQ42605133
Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heartQ42735515
Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptorsQ42944340
Epidemiology, control and surveillance of Chagas disease: 100 years after its discoveryQ43309611
Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypesQ44211055
Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturationQ44522457
The Chagas' disease parasite Trypanosoma cruzi exploits nerve growth factor receptor TrkA to infect mammalian hostsQ46898405
Bradykinin does not induce gap formation between human endothelial cellsQ46971514
Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathwayQ48313363
Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomesQ28572060
A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma bruceiQ29617358
Transcellular diapedesis is initiated by invasive podosomesQ30480733
p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylationQ30483820
Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edgesQ32066430
The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and eliminationQ33372349
Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cellsQ33484728
Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartmentQ33591084
Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivoQ33745197
Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunityQ33809208
Current and developing therapeutic agents in the treatment of Chagas diseaseQ34170132
Cross-talk between the complement and the kinin system in vascular permeabilityQ35182755
A factor from Trypanosoma cruzi induces repetitive cytosolic free Ca2+ transients in isolated primary canine cardiac myocytesQ35491099
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.Q35747889
Axenic culture of African trypanosome bloodstream formsQ35846319
Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy.Q36024864
Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transportQ36237039
The Trypanosoma cruzi-host-cell interplay: location, invasion, retentionQ36263007
A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctionsQ36356682
Role in host cell invasion of Trypanosoma cruzi-induced cytosolic-free Ca2+ transientsQ36362903
Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicryQ36385476
Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells.Q36399371
Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivoQ36445579
The vasculature in chagas diseaseQ36569125
Recent developments in the interactions between caveolin and pathogensQ36586691
Molecular events during leukocyte diapedesisQ36590776
Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruziQ36691584
Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruziQ36885459
Dual regulation of endothelial junctional permeabilityQ37000246
Molecular and cellular mechanisms involved in the Trypanosoma cruzi/host cell interplayQ37007967
Perspectives on the Trypanosoma cruzi-host cell receptor interactionsQ37227797
Mechanisms of transendothelial migration of leukocytesQ37336596
Assays of transendothelial migration in vitroQ37382313
Settings and mechanisms for trans-cellular diapedesisQ37501799
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectTrypanosoma cruziQ150162
P304page(s)e81187
P577publication date2013-01-01
P1433published inPLOS OneQ564954
P1476titleEndothelial transmigration by Trypanosoma cruzi
P478volume8

Reverse relations

cites work (P2860)
Q91415039A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy
Q41205225Angiophagy: clearing or clogging microvessels?
Q39146653Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
Q57789637Pathology and Pathogenesis of Chagas Heart Disease

Search more.